Skip to main content
PMC home page
Clinical and Experimental Immunology logoLink to Clinical and Experimental Immunology
. 1976 Apr;24(1):54–62.

Mechanisms of corticosteroid action on lymphocyte subpopulations. II. Differential effects of in vivo hydrocortisone, prednisone and dexamethasone on in vitro expression of lymphocyte function.

A S Fauci
PMCID: PMC1538503  PMID: 1084818

Abstract

The present study was undertaken to determine what, if any, differential effect various commonly used corticosteroid preparations had on the numbers and specific functions of lymphocyte subpopulations when these agents were administered in equivalent pharmacological dosages. Normal volunteers received a single dose of either 320 mg of hydrocortisone intravenously, 80 mg of prednisone orally, or 12 mg of dexamethasone orally. There was a marked lymphocytopenia and monocytopenia maximal 4-6 hr following administration of all three corticosteroid preparations with almost identical kinetics and degree of fall in total cell numbers as well as proportions of thymus-derived and bone marrow-derived lymphocytes. Hydrocortisone and prednisone caused only a slight suppression of phytohaemagglutiinin (PHA) induced lymphocyte blastogensis which could be reversed at supra-optimal concentrations of PHA. On the contrary, dexamethasone administration casued a marked suppression of PHA responses which was not reversed by supra-optimal PHA stimulation. In addition, hydrocortisone and prednisone administration did not suppress non-specific PHA-induced cellular cytotoxcity, while dexamethasone caused a marked suppression (P less than 0.001) of cytotoxicity. These studies show that although equivalent anti-inflammatory doses of these three corticosteroid preparations cause almost identical suppression of the numbers of circulating lymphocyte populations, they have a differential effect of the numbers of circulating lymphocyte populations, they have a differential effect on a certain in vitro functional correlates of cell-mediated immunity.

Full text

PDF
54

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. BOGGS D. R., ATHENS J. W., CARTWRIGHT G. E., WINTROBE M. M. THE EFFECT OF ADRENAL GLUCOCORTICOSTEROIDS UPON THE CELLULAR COMPOSITION OF INFLAMMATORY EXUDATES. Am J Pathol. 1964 May;44:763–773. [PMC free article] [PubMed] [Google Scholar]
  2. Bagby G. C., Jr, Goldman R. D., Newman H. C., Means J. F. Acute myocardial infarction due to childhood lymphoma. N Engl J Med. 1972 Aug 17;287(7):338–340. doi: 10.1056/NEJM197208172870707. [DOI] [PubMed] [Google Scholar]
  3. Balow J. E., Hurley D. L., Fauci A. S. Immunosuppressive effects of glucocorticosteroids: differential effects of acute vs chronic administration on cell-mediated immunity. J Immunol. 1975 Mar;114(3):1072–1076. [PubMed] [Google Scholar]
  4. Bianco C., Patrick R., Nussenzweig V. A population of lymphocytes bearing a membrane receptor for antigen-antibody-complement complexes. I. Separation and characterization. J Exp Med. 1970 Oct 1;132(4):702–720. doi: 10.1084/jem.132.4.702. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Butler W. T., Rossen R. D. Effects of corticosteroids on immunity in man. I. Decreased serum IgG concentration caused by 3 or 5 days of high doses of methylprednisolone. J Clin Invest. 1973 Oct;52(10):2629–2640. doi: 10.1172/JCI107455. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Cohen J. J. Thymus-derived lymphocytes sequestered in the bone marrow of hydrocortisone-treated mice. J Immunol. 1972 Mar;108(3):841–844. [PubMed] [Google Scholar]
  7. Fauci A. S. Corticosteroids and circulating lymphocytes. Transplant Proc. 1975 Mar;7(1):37–40. [PubMed] [Google Scholar]
  8. Fauci A. S., Dale D. C. Alternate-day prednisone therapy and human lymphocyte subpopulations. J Clin Invest. 1975 Jan;55(1):22–32. doi: 10.1172/JCI107914. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Fauci A. S., Dale D. C. The effect of Hydrocortisone on the kinetics of normal human lymphocytes. Blood. 1975 Aug;46(2):235–243. [PubMed] [Google Scholar]
  10. Fauci A. S., Dale D. C. The effect of in vivo hydrocortisone on subpopulations of human lymphocytes. J Clin Invest. 1974 Jan;53(1):240–246. doi: 10.1172/JCI107544. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Fauci A. S. Mechanisms of corticosteroid action on lymphocyte subpopulations. I. Redistribution of circulating T and b lymphocytes to the bone marrow. Immunology. 1975 Apr;28(4):669–680. [PMC free article] [PubMed] [Google Scholar]
  12. Fauve R. M., Pierce-Chase C. H. Comparative effects of corticosteroids on host resistance to infection in relation to chemical structure. J Exp Med. 1967 May 1;125(5):807–821. doi: 10.1084/jem.125.5.807. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Frank M. M., Gaither T. The effect of temperature on the reactivity of guinea-pig complement with gamma G and gamma M haemolytic antibodies. Immunology. 1970 Dec;19(6):967–974. [PMC free article] [PubMed] [Google Scholar]
  14. Gabrielsen A. E., Good R. A. Chemical suppression of adaptive immunity. Adv Immunol. 1967;6:91–229. doi: 10.1016/s0065-2776(08)60522-2. [DOI] [PubMed] [Google Scholar]
  15. Jondal M., Holm G., Wigzell H. Surface markers on human T and B lymphocytes. I. A large population of lymphocytes forming nonimmune rosettes with sheep red blood cells. J Exp Med. 1972 Aug 1;136(2):207–215. doi: 10.1084/jem.136.2.207. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Jondal M., Wigzell H., Aiuti F. Human lymphocyte subpopulations: classification according to surface markers and-or functional characteristics. Transplant Rev. 1973;16:163–195. doi: 10.1111/j.1600-065x.1973.tb00120.x. [DOI] [PubMed] [Google Scholar]
  17. Kirchner H., Blaese R. M. Pokeweed mitogen-, concanavalin A-, and phytohemagglutinin-induced development of cytotoxic effector lymphocytes. An evaluation of the mechanisms of T cell-mediated cytotoxicity. J Exp Med. 1973 Oct 1;138(4):812–824. doi: 10.1084/jem.138.4.812. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. LERNER L. J., BIANCHI A., TURKHEIMER A. R., SINGER F. M., BORMAN A. ANTI-INFLAMMATORY STEROIDS: POTENCY, DURATION AND MODIFICATION OF ACTIVITIES. Ann N Y Acad Sci. 1964 Aug 27;116:1071–1077. doi: 10.1111/j.1749-6632.1964.tb52569.x. [DOI] [PubMed] [Google Scholar]
  19. LIDDLE G. W. Clinical pharmacology of the anti-inflammatory steroids. Clin Pharmacol Ther. 1961 Sep-Oct;2:615–635. doi: 10.1002/cpt196125615. [DOI] [PubMed] [Google Scholar]
  20. Muchmore A. V., Nelson D. L., Kirchner H., Blaese R. M. A reappraisal of the effector cells mediating mitogen induced cellular cytotoxicity. Cell Immunol. 1975 Sep;19(1):78–90. doi: 10.1016/0008-8749(75)90293-2. [DOI] [PubMed] [Google Scholar]
  21. Möller G., Sjöberg O., Andersson J. Mitogen-induced lymphocyte-mediated cytotoxicity in vitro: effect of mitogens selectively activating T or B cells. Eur J Immunol. 1972 Dec;2(6):586–592. doi: 10.1002/eji.1830020621. [DOI] [PubMed] [Google Scholar]
  22. Perlmann P., Holm G. Cytotoxic effects of lymphoid cells in vitro. Adv Immunol. 1969;11:117–193. doi: 10.1016/s0065-2776(08)60479-4. [DOI] [PubMed] [Google Scholar]
  23. Perlmann P., Perlmann H., Holm G. Cytotoxic action of stimulated lymphocytes on allogenic and autologous erythrocytes. Science. 1968 Apr 19;160(3825):306–309. doi: 10.1126/science.160.3825.306. [DOI] [PubMed] [Google Scholar]
  24. Peters W. P., Holland J. F., Senn H., Rhomberg W., Banerjee T. Corticosteroid administration and localized leukocyte mobilization in man. N Engl J Med. 1972 Feb 17;286(7):342–345. doi: 10.1056/NEJM197202172860703. [DOI] [PubMed] [Google Scholar]
  25. REBUCK J. W., MELLINGER R. C. Interruption by topical cortisone of leukocytic cycles in acute inflammation in man. Ann N Y Acad Sci. 1953 Jul 17;56(4):715–732. doi: 10.1111/j.1749-6632.1953.tb27394.x. [DOI] [PubMed] [Google Scholar]
  26. Sherwood G., Blaese R. M. Phytohaemagglutinin-induced cytotoxic effector lymphocyte function in patients with the Wiskott-Aldrich syndrome (WAS). Clin Exp Immunol. 1973 Apr;13(4):515–520. [PMC free article] [PubMed] [Google Scholar]
  27. Thorn G. W. Clinical considerations in the use of corticosteroids. N Engl J Med. 1966 Apr 7;274(14):775–781. doi: 10.1056/NEJM196604072741406. [DOI] [PubMed] [Google Scholar]
  28. Webel M. L., Ritts R. E., Jr, Taswell H. F., Danadio J. V., Jr, Woods J. E. Cellular immunity after intravenous administration of methylprednisolone. J Lab Clin Med. 1974 Mar;83(3):383–392. [PubMed] [Google Scholar]
  29. Yu D. T., Clements P. J., Paulus H. E., Peter J. B., Levy J., Barnett E. V. Human lymphocyte subpopulations. Effect of corticosteroids. J Clin Invest. 1974 Feb;53(2):565–571. doi: 10.1172/JCI107591. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Clinical and Experimental Immunology are provided here courtesy of British Society for Immunology

RESOURCES